Eli Lilly and Company (LLY) Earnings Date, Estimates & Call Transcripts $921.72 +6.68 (+0.73%) (As of 09/20/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 7EstimatedActual EPS (Aug. 8) $3.92 Beat By $1.28 Consensus EPS (Aug. 8) $2.64 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLLY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LLY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt industries worth over $46 trillion. What's even more intriguing?Click here to uncover how you can get in on the ground floor. Eli Lilly and Company Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$2.34$2.74$2.54 Q2 20243$2.41$2.89$2.64 Q3 20243$2.93$4.39$3.72 Q4 20243$3.04$5.47$4.47 FY 202412$10.72$15.49$13.37 Q1 20251$4.72$4.72$4.72 Q2 20251$5.21$5.21$5.21 Q3 20251$6.21$6.21$6.21 Q4 20251$7.59$7.59$7.59 FY 20254$23.73$23.73$23.73 Q1 20261$6.24$6.24$6.24 Q2 20261$7.02$7.02$7.02 LLY Earnings Date and InformationEli Lilly and Company last released its earnings results on August 8th, 2024. The reported $3.92 EPS for the quarter, beating the consensus estimate of $2.64 by $1.28. The business earned $11.30 billion during the quarter, compared to analyst estimates of $9.83 billion. Eli Lilly and Company has generated $6.79 earnings per share over the last year ($6.79 diluted earnings per share) and currently has a price-to-earnings ratio of 135.7. Earnings for Eli Lilly and Company are expected to grow by 45.36% in the coming year, from $16.49 to $23.97 per share. Eli Lilly and Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off prior year's report dates.Read More Eli Lilly and Company Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/7/2024(Estimated)------- 8/8/2024Q2 2024$2.64$3.92+$1.28$4.56$9.83 billion$11.30 billion5/6/2024Q1 2024$2.53$2.58+$0.05$2.68$8.94 billion$8.77 billion 2/6/2024Q4 2023$2.30$2.49+$0.19$2.56$8.95 billion$9.35 billion 11/2/2023Q3 2023($0.08)$0.10+$0.18$0.26$8.88 billion$9.50 billion 8/8/2023Q2 2023$1.98$2.11+$0.13$2.27$7.58 billion$8.31 billion 4/27/2023Q1 2023$1.73$1.62($0.11)$1.75$6.87 billion$6.96 billion Forget Trump and Kamala (Ad)Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.Download my Dividend Calendar here2/2/2023Q4 2022$1.83$2.09+$0.26$2.04$7.39 billion$7.30 billion 11/1/2022Q3 2022$1.97$1.98+$0.01$2.35$6.91 billion$6.94 billion 8/4/2022Q2 2022$1.80$1.25($0.55)$1.45$6.85 billion$6.49 billion 4/28/2022Q1 2022$2.32$2.62+$0.30$3.14$7.29 billion$7.81 billion 2/3/2022Q4 2021$2.51$2.49($0.02)$3.08$7.89 billion$8.00 billion 10/25/2021Q3 2021$1.98$1.94($0.04)$2.66$6.64 billion$6.77 billion 8/2/2021Q2 2021$1.89$1.87($0.02)$2.21$6.59 billion$6.74 billion 4/26/2021Q1 2021$2.12$1.87($0.25)$2.25$7.10 billion$6.81 billion 1/28/2021Q4 2020$2.35$2.75+$0.40$3.18$7.27 billion$7.44 billion 11/1/2020Q3 2020$1.71$1.54($0.17)$1.75$5.87 billion$5.74 billion 7/30/2020Q2 2020$1.58$1.89+$0.31$2.23$5.77 billion$5.50 billion 4/23/2020Q1 2020$1.48$1.75+$0.27$1.90$5.48 billion$5.86 billion 1/30/2020Q4 2019$1.52$1.73+$0.21$1.82$5.92 billion$6.11 billion 10/23/2019Q3 2019$1.43$1.48+$0.05$1.59$5.50 billion$5.48 billion Eli Lilly and Company Earnings - Frequently Asked Questions When is Eli Lilly and Company's earnings date? Eli Lilly and Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates. Learn more on LLY's earnings history. What guidance has Eli Lilly and Company issued on next quarter's earnings? Eli Lilly and Company updated its FY 2024 earnings guidance on Thursday, August, 8th. The company provided EPS guidance of 16.100-16.600 for the period, compared to the consensus EPS estimate of 13.760. The company issued revenue guidance of $45.4 billion-$46.6 billion, compared to the consensus revenue estimate of $43.0 billion. Did Eli Lilly and Company beat their earnings estimates last quarter? In the previous quarter, Eli Lilly and Company (NYSE:LLY) reported $3.92 earnings per share (EPS) to beat the analysts' consensus estimate of $2.64 by $1.28. Learn more on analysts' earnings estimate vs. LLY's actual earnings. How much revenue does Eli Lilly and Company generate each year? Eli Lilly and Company (NYSE:LLY) has a recorded annual revenue of $38.92 billion. How much profit does Eli Lilly and Company generate each year? Eli Lilly and Company (NYSE:LLY) has a recorded net income of $5.24 billion. LLY has generated $6.79 earnings per share over the last four quarters. What is Eli Lilly and Company's price-to-earnings ratio? Eli Lilly and Company (NYSE:LLY) has a trailing price-to-earnings ratio of 135.75 and a forward price-to-earnings ratio of 55.90. The price/earnings-to-growth ratio is 2.79. What is Eli Lilly and Company's EPS forecast for next year? Eli Lilly and Company's earnings are expected to grow from $16.49 per share to $23.97 per share in the next year, which is a 45.36% increase. More Earnings Resources from MarketBeat Related Companies: Johnson & Johnson Earnings Results AbbVie Earnings Results Merck & Co., Inc. Earnings Results Pfizer Earnings Results Bristol-Myers Squibb Earnings Results Zoetis Earnings Results Royalty Pharma Earnings Results Jazz Pharmaceuticals Earnings Results Corcept Therapeutics Earnings Results Perrigo Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NYSE:LLY) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Eli Lilly and Company You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
